BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8613360)

  • 1. Trypanosoma cruzi-induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathway.
    Lopes MF; DosReis GA
    Infect Immun; 1996 May; 64(5):1559-64. PubMed ID: 8613360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
    Nunes MP; Andrade RM; Lopes MF; DosReis GA
    J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
    Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
    Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning.
    Lopes MF; dos Reis GA
    Infect Immun; 1994 Apr; 62(4):1484-8. PubMed ID: 8132357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease.
    Lopes MF; da Veiga VF; Santos AR; Fonseca ME; DosReis GA
    J Immunol; 1995 Jan; 154(2):744-52. PubMed ID: 7814881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis as a cause of T-cell unresponsiveness in experimental Chagas' disease.
    Lopes MF; DosReis GA
    Braz J Med Biol Res; 1995 Aug; 28(8):913-8. PubMed ID: 8555995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: both chemically induced and triatomine-derived metacyclic trypomastigotes cause the same immunological disturbances in the infected mammalian host.
    Lopes MF; Cunha JM; Bezerra FL; Gonzalez MS; Gomes JE; Lapa e Silva JR; Garcia ES; Dos Reis GA
    Exp Parasitol; 1995 Mar; 80(2):194-204. PubMed ID: 7895831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of T lymphocyte activation in vitro and in vivo induced by glycoinositolphospholipids from Trypanosoma cruzi. Assignment of the T cell-suppressive determinant to the ceramide domain.
    Gomes NA; Previato JO; Zingales B; Mendonça-Previato L; DosReis GA
    J Immunol; 1996 Jan; 156(2):628-35. PubMed ID: 8543814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infection.
    Nunes MP; Fortes B; Silva-Filho JL; Terra-Granado E; Santos L; Conde L; de Araújo Oliveira I; Freire-de-Lima L; Martins MV; Pinheiro AA; Takyia CM; Freire-de-Lima CG; Todeschini AR; Dosreis GA; Morrot A
    PLoS One; 2013; 8(10):e77568. PubMed ID: 24204874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.
    Michailowsky V; Luhrs K; Rocha MO; Fouts D; Gazzinelli RT; Manning JE
    Infect Immun; 2003 Jun; 71(6):3165-71. PubMed ID: 12761095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic experimental Chagas' disease: functional syngeneic T-B-cell cooperation in vitro in the absence of an exogenous stimulus.
    Freire-de-Lima C; Peçanha LM; Dos Reis GA
    Infect Immun; 1996 Jul; 64(7):2861-6. PubMed ID: 8698526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock.
    Jacobs F; Dubois C; Carlier Y; Goldman M
    Clin Exp Immunol; 1996 Feb; 103(2):233-8. PubMed ID: 8565305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Trypanosoma cruzi infection differentially affects CD3 and Thy-1 mediated T cell activation.
    de Oliveira GA; Gattass CR
    Immunol Lett; 1991 Jun; 28(3):227-32. PubMed ID: 1679416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection.
    Graefe SE; Jacobs T; Wächter U; Bröker BM; Fleischer B
    Parasite Immunol; 2004 Jan; 26(1):19-28. PubMed ID: 15198642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4
    Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
    Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.